Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04086862 · ClinicalTrials.gov registry record · NA
Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Comparison of 1 Megahertz Versus 3 Megahertz
A NA study of Adult Females and Bilateral Masseter Myalgia, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04086862 is a NA study of Adult Females and Bilateral Masseter Myalgia that has completed, run by State University of New York at Buffalo. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04086862, a NA study of Adult Females and Bilateral Masseter Myalgia, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Temporomandibular disorders (TMD) are a group of musculoskeletal and neuromuscular conditions that involve the temporomandibular joints, the masticatory muscles, and all associated tissues. These disorders are characterized by regional pain and limitation of mandibular range of motion. Pain-related TMD affects approximately 5% to 12% of the population and can affect individual's quality of life. The incidence is about 4 percent. Therapeutic ultrasound is a type of physical therapy that delivers energy via propagation of ultrasonic waves. One gap in knowledge is whether 1 megahertz (MHz) treating frequency has the same efficacy as treating with 3 MHz. This research proposes to test that.
Conditions Studied
Interventions
- PROCEDURE Therapeutic ultrasound
Study Locations (1)
New York
- School of Dental Medicine - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2021-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04086862
The ClinicalTrials.gov registry entry for NCT04086862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Adult Females appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic ultrasound is the first listed.
NCT04086862 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04086862 about?
NCT04086862 is a clinical study titled "Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Comparison of 1 Megahertz Versus 3 Megahertz". Temporomandibular disorders (TMD) are a group of musculoskeletal and neuromuscular conditions that involve the temporomandibular joints, the masticatory muscles, and all associated tissues. These disorders are characterized by regional pain and limitation of mandibular range of motion. Pain-related ...
What is the current status of trial NCT04086862?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-10-24. Estimated completion is 2021-03-20.
What conditions does trial NCT04086862 study?
This clinical trial studies the following conditions: Adult Females, Bilateral Masseter Myalgia.
What interventions are being tested in trial NCT04086862?
The interventions under investigation include: Therapeutic ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT04086862?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04086862 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.